HAMMERMAN, Ariel; GREENBERG-DOTAN, Sari; BATTAT, Erez; FELDHAMER, Ilan; BITTERMAN, Haim; BRENNER, Baruch. The ‘real-life’ impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: A large Israeli retrospective cohort study. Acta Oncologica, [S. l.], v. 54, n. 2, p. 164–170, 2015. DOI: 10.3109/0284186X.2014.958532. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/25812. Acesso em: 17 may. 2026.